Clustering of mutations associated with mild Marfan-like phenotypes in the 3' region of FBN1 suggests a potential genotype-phenotype correlation.

Mutations in the gene for fibrillin-1 (FBN1) cause Marfan syndrome, a dominantly inherited disorder of connective tissue that primarily involves the cardiovascular, ocular, and skeletal systems. There is a remarkable degree of variability both within and between families with Marfan syndrome, and FBN1 mutations have also been found in a range of other related connective tissue disorders collectively termed type-1 fibrillinopathies. FBN1 mutations have been found in almost all of the 65 exons of the FBN1 gene and for the most part have been unique to one affected patient or family. Aside from the "hot spots" for the neonatal Marfan syndrome in exons 24-27 and 31-32, genotype-phenotype correlations have been slow to emerge. Here we present the results of temperature-gradient gel electrophoresis analysis of FBN1 exons 59-65. Six mutations were identified, only one of which had been previously reported. Two of the six mutations were found in patients with mild phenotypes. Taken together with other published reports, our results suggest that a sizable subset (ca. 40%) of mutations in this region is associated with mild phenotypes characterized by the lack of significant aortic pathology, compared with about 7% in the rest of the gene. In two cases, mutations affecting analogous positions within one of the 43 cbEGF modules of FBN1 are associated with mild phenotypes when found in one of the 6 C-terminal modules (encoded by exons 59-63), but are associated with classic or severe phenotypes when found in cbEGF modules elsewhere in the gene.

[1]  L. Peltonen,et al.  Mutations in the fibrillin gene responsible for dominant ectopia lentis and neonatal Marfan syndrome , 1994, Nature Genetics.

[2]  D. Milewicz,et al.  A mutation in FBN1 disrupts profibrillin processing and results in isolated skeletal features of the Marfan syndrome. , 1995, The Journal of clinical investigation.

[3]  D. Sillence,et al.  International Nosology of Heritable Disorders of Connective Tissue, Berlin, 1986. , 1988, American journal of medical genetics.

[4]  H. Dietz,et al.  Four novel FBN1 mutations: significance for mutant transcript level and EGF-like domain calcium binding in the pathogenesis of Marfan syndrome. , 1993, Genomics.

[5]  C. Hayward,et al.  Identification of a novel nonsense mutation in the fibrillin gene (FBN1) using nonisotopic techniques , 1994, Human mutation.

[6]  C. Hayward,et al.  Fibrillin‐1 mutations in Marfan syndrome and other type‐1 fibrillinopathies , 1997, Human mutation.

[7]  L. Peltonen,et al.  Recurrence of Marfan syndrome as a result of parental germ-line mosaicism for an FBN1 mutation. , 1999, American journal of human genetics.

[8]  M. Hentze,et al.  Binary specification of nonsense codons by splicing and cytoplasmic translation , 1998, The EMBO journal.

[9]  B. Burton,et al.  Three novel fibrillin mutations in exons 25 and 27: Classic versus neonatal Marfan syndrome , 1997, Human mutation.

[10]  L. Peltonen,et al.  An extra cysteine in one of the non-calcium-binding epidermal growth factor-like motifs of the FBN1 polypeptide is connected to a novel variant of Marfan syndrome. , 1994, The Journal of clinical investigation.

[11]  L. Peltonen,et al.  Evidence for furin-type activity-mediated C-terminal processing of profibrillin-1 and interference in the processing by certain mutations. , 1998, Human molecular genetics.

[12]  C. Larsson,et al.  Homozygotes for the autosomal dominant neoplasia syndrome (MEN1). , 1993, American journal of human genetics.

[13]  U. Francke,et al.  A Gly1127Ser mutation in an EGF-like domain of the fibrillin-1 gene is a risk factor for ascending aortic aneurysm and dissection. , 1995, American journal of human genetics.

[14]  B. Sykes,et al.  A novel fibrillin mutation in the Marfan syndrome which could disrupt calcium binding of the epidermal growth factor-like module. , 1993, Human molecular genetics.

[15]  R E Pyeritz,et al.  Revised diagnostic criteria for the Marfan syndrome. , 1996, American journal of medical genetics.

[16]  M. Passos-Bueno,et al.  Identification of 8 new mutations in Brazilian families with Marfan syndrome , 1999, Human mutation.

[17]  B. Giusti,et al.  A major involvement of the cardiovascular system in patients affected by Marfan syndrome: novel mutations in fibrillin 1 gene. , 1997, Journal of molecular and cellular cardiology.

[18]  C. Hayward,et al.  Mutation screening of all 65 exons of the fibrillin‐1 gene in 60 patients with Marfan syndrome: Report of 12 novel mutations , 1997, Human mutation.

[19]  D. Baty,et al.  Correlation of a recurrent FBN1 mutation (R122C) with an atypical familial marfan syndrome phenotype , 1998, Human Mutation.

[20]  L. Peltonen,et al.  A novel mutation of the fibrillin gene causing ectopia lentis. , 1994, Genomics.

[21]  L. Lerman,et al.  Computational simulation of DNA melting and its application to denaturing gradient gel electrophoresis. , 1987, Methods in enzymology.

[22]  W. Hu,et al.  Developmental expression of fibrillin genes suggests heterogeneity of extracellular microfibrils , 1995, The Journal of cell biology.

[23]  U. Francke,et al.  Mutant fibrillin-1 monomers lacking EGF-like domains disrupt microfibril assembly and cause severe marfan syndrome. , 1996, Human molecular genetics.

[24]  B. Sykes,et al.  Genomic organization of the sequence coding for fibrillin, the defective gene product in Marfan syndrome. , 1993, Human molecular genetics.

[25]  L. Peltonen,et al.  A compound-heterozygous Marfan patient: two defective fibrillin alleles result in a lethal phenotype. , 1994, American journal of human genetics.

[26]  L. Peltonen,et al.  Two mutations in Marfan syndrome resulting in truncated fibrillin polypeptides. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[27]  M. Raghunath,et al.  Carboxy-terminal conversion of profibrillin to fibrillin at a basic site by PACE/furin-like activity required for incorporation in the matrix. , 1999, Journal of cell science.

[28]  R E Pyeritz,et al.  Fifteen novel FBN1 mutations causing Marfan syndrome detected by heteroduplex analysis of genomic amplicons. , 1995, American journal of human genetics.

[29]  C. Hayward,et al.  A novel mutation in the fibrillin gene (FBN1) in familial arachnodactyly. , 1994, Molecular and cellular probes.

[30]  C. Detter,et al.  A novel mutation in the neonatal region of the fibrillin (FBN) 1 gene associated with a classical phenotype of Marfan syndrome (MfS) , 1998, Human mutation.

[31]  Hanns-Georg Klein,et al.  Marfan Database (third edition): new mutations and new routines for the software , 1998, Nucleic Acids Res..

[32]  U. Francke,et al.  Mutation screening of complete fibrillin-1 coding sequence: report of five new mutations, including two in 8-cysteine domains. , 1993, Human molecular genetics.

[33]  R. Mecham,et al.  N-terminal domains of fibrillin 1 and fibrillin 2 direct the formation of homodimers: a possible first step in microfibril assembly. , 1999, The Biochemical journal.

[34]  P. Robinson,et al.  Novel exon skipping mutation in the fibrillin‐1 gene: Two ‘hot spots’ for the neonatal Marfan syndrome , 1999, Clinical genetics.